Glycoproteomics in neurodegenerative diseases
Year: 2009
Type: review
Abstract: Protein glycosylation regulates protein function and cellular distribution. Additionally, aberrant protein glycosylations have been recognized to play major roles in human disorders, including neurodegenerative diseases. Glycoproteomics, a branch of proteomics that catalogs and quantifies glycoproteins, provides a powerful means to systematically profile the glycopeptides or glycoproteins of a complex mixture that are highly enriched in body fluids, and therefore, carry great potential to be diagnostic and/or prognostic markers. Application of this mass spectrometry-based technology to the study of neurodegenerative disorders (e.g., Alzheimer's disease and Parkinson's disease) is relatively new, and is expected to provide insight into the biochemical pathogenesis of neurodegeneration, as well as biomarker discovery. In this review, we have summarized the current understanding of glycoproteins in biology and neurodegenerative disease, and have discussed existing proteomic technologies that are utilized to characterize glycoproteins. Some of the ongoing studies, where glycoproteins isolated from cerebrospinal fluid and human brain are being characterized in Parkinson's disease at different stages versus controls, are presented, along with future applications of targeted validation of brain specific glycoproteins in body fluids.
Source: Mass Spectrometry Reviews
DOI: 10.1002/mas.20221
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: Post-translational Modifications of Proteins in Parkinson?s disease, Proteomic Studies in Parkinson's Disease, Biomarkers for Preclinical Parkinson's disease, Detecting Biomarkers in Plasma for Diagnosing Neurodegenerative Diseases, Michigan Alzheimer's Disease Research Center, Biomarkers for Parkinson's Disease (PD) and PD Dementia, Alzheimer's Disease Research Center
OpenAlex ID: W2128909115
